Biomedical Engineering Reference
In-Depth Information
25. Xiao X, Li J, McCown TJ et al (1997) Gene
transfer by adeno-associated virus vectors into
the central nervous system. Exp Neurol 144:
113-124
26. Li J, Wang D, Qian S et al (2003) Effi cient
and long-term intracardiac gene transfer in
delta-sarcoglycan-defi ciency hamster by
adeno-associated virus-2 vectors. Gene Ther
10:1807-1813
27. Monahan PE, Samulski RJ, Tazelaar J et al
(1998) Direct intramuscular injection with
recombinant AAV vectors results in sustained
expression in a dog model of hemophilia.
Gene Ther 5:40-49
28. Grieger JC, Samulski RJ (2012) Adeno-
associated virus vectorology, manufacturing,
and clinical applications. Methods Enzymol
507:229-254
29. Harris JA, Devidze N, Verret L et al (2010)
Transsynaptic progression of amyloid-beta-
induced neuronal dysfunction within the
entorhinal-hippocampal network. Neuron
68:428-441
30. Wu Z, Asokan A, Grieger JC et al (2006)
Single amino acid changes can infl uence titer,
heparin binding, and tissue tropism in differ-
ent adeno-associated virus serotypes. J Virol
80:11393-11397
31. Samulski RJ, Berns KI, Tan M et al (1982)
Cloning of adeno-associated virus into
pBR322: rescue of intact virus from the
recombinant plasmid in human cells. Proc
Natl Acad Sci U S A 79:2077-2081
32. Burger C, Gorbatyuk OS, Velardo MJ et al
(2004) Recombinant AAV viral vectors pseu-
dotyped with viral capsids from serotypes 1,
2, and 5 display differential effi ciency and cell
tropism after delivery to different regions of
the central nervous system. Mol Ther 10:
302-317
33. Cearley CN, Wolfe JH (2006) Transduction
characteristics of adeno-associated virus vec-
tors expressing cap serotypes 7, 8, 9, and
Rh10 in the mouse brain. Mol Ther 13:
528-537
34. Klein RL, Dayton RD, Tatom JB et al (2008)
Tau expression levels from various adeno-
associated virus vector serotypes produce
graded neurodegenerative disease states. Eur
J Neurosci 27:1615-1625
35. Choi VW, McCarty DM, Samulski RJ (2005)
AAV hybrid serotypes: improved vectors for
gene delivery. Curr Gene Ther 5:299-310
36. Parks WP, Boucher DW, Melnick JL et al
(1970) Seroepidemiological and ecological
studies of the adenovirus-associated satellite
viruses. Infect Immun 2:716-722
37. Xiao W, Chirmule N, Berta SC et al (1999)
Gene therapy vectors based on adeno-
associated virus type 1. J Virol 73:
3994-4003
38. Zincarelli C, Soltys S, Rengo G et al (2008)
Analysis of AAV serotypes 1-9 mediated gene
expression and tropism in mice after systemic
injection. Mol Ther 16:1073-1080
39. Gao G, Vandenberghe LH, Alvira MR et al
(2004) Clades of adeno-associated viruses are
widely disseminated in human tissues. J Virol
78:6381-6388
40. Klein RL, Dayton RD, Leidenheimer NJ et al
(2006) Effi cient neuronal gene transfer with
AAV8 leads to neurotoxic levels of tau or
green fl uorescent proteins. Mol Ther 13:
517-527
41. Gray SJ, Matagne V, Bachaboina L et al
(2011) Preclinical differences of intravascular
AAV9 delivery to neurons and glia: a com-
parative study of adult mice and nonhuman
primates. Mol Ther 19:1058-1069
42. Dodiya HB, Bjorklund T, Stansell J 3rd et al
(2010) Differential transduction following
basal ganglia administration of distinct pseu-
dotyped AAV capsid serotypes in nonhuman
primates. Mol Ther 18:579-587
43. Foust KD, Nurre E, Montgomery CL et al
(2009) Intravascular AAV9 preferentially tar-
gets neonatal neurons and adult astrocytes.
Nat Biotechnol 27:59-65
44. Bevan AK, Duque S, Foust KD et al (2011)
Systemic gene delivery in large species for tar-
geting spinal cord, brain, and peripheral tis-
sues for pediatric disorders. Mol Ther 19:
1971-1980
45. Dayton RD, Wang DB, Klein RL (2012) The
advent of AAV9 expands applications for
brain and spinal cord gene delivery. Expert
Opin Biol Ther 12:757-766
46. Allay JA, Sleep S, Long S et al (2011) Good
manufacturing practice production of self-
complementary serotype 8 adeno-associated
viral vector for a hemophilia B clinical trial.
Hum Gene Ther 22:595-604
47. Masamizu Y, Okada T, Kawasaki K et al
(2011) Local and retrograde gene transfer
into primate neuronal pathways via adeno-
associated virus serotype 8 and 9. Neuroscience
193:249-258
48. Gray SJ, Blake BL, Criswell HE et al (2010)
Directed evolution of a novel adeno-
associated virus (AAV) vector that crosses the
seizure-compromised blood-brain barrier
(BBB). Mol Ther 18:570-578
49. Bowles DE, McPhee SW, Li C et al (2012)
Phase 1 gene therapy for Duchenne muscular
Search WWH ::
Custom Search